Ushbu ishga iqtibos qilgan ishlar

8 ta ish

Ish: A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

1. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

   S. Moe, M. L. Rekart, D. Hernandez +9

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20232 iqtibos

   ABIABI:AkademIndex/2026.other.281628

2. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

   Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyClinical Infectious Diseases20251 iqtibos

   ABIABI:AkademIndex/2025.article.000230

3. Introducing BPaL: Experiences from countries supported under the LIFT-TB project

   D. F. Wares, M. Mbenga, Veriko Mirtskhulava +19

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyPLoS ONE20240 iqtibos

   ABIABI:AkademIndex/2024.article.000471

4. How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

   Ilaria Motta, Martina Cusinato, Andrew Ludman +15

   MaqolaOAOchiq kirishCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy20240 iqtibos

   ABIABI:AkademIndex/2024.article.000869

5. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   MaqolaOAOchiq kirish20240 iqtibos

   ABIABI:AkademIndex/2024.article.018556

6. Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study

   Karen Lowton, Beverley Stringer, M. Cusinato +7

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyIJTLD OPEN20260 iqtibos

   ABIABI:AkademIndex/2026.article.016746

7. Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan—A Retrospective Cohort Study

   Matthew J Saunders, Ekaterine Garsevanidze, Sholpan Allamuratova +14

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.038930

8. Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB

   Harald Hoffmann, Andrey Golubov, Caroline S. Corbett +8

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.059307